HTGM - HTGモレキュラ―・ダイアグノスティックス (HTG Molecular Diagnostics Inc.) HTGモレキュラ―・ダイアグノスティックス

 HTGMのチャート


 HTGMの企業情報

symbol HTGM
会社名 HTG Molecular Diagnostics Inc (HTGモレキュラ―・ダイアグノスティックス)
分野(sector) Capital Goods   資本財(工業製品)
産業(industry) Biotechnology: Laboratory Analytical Instruments  
業種 先端医療機器_テクノロジ―   医療関連(Health Care)
概要 事業概要 HTG・モレキュラー・ダイアグノスティックス(HTG Molecular Diagnostics Inc)はトランスレーショナルリサーチ・医学及び分子診断学ためmRNA測定、及びマイクロRNA(miRNA)ため製品の提供に従事する米国の会社である。同社の定量的ヌクレアーゼプロテクションアッセイ(qNPA)分子技術プラットフォームは、特にホルマリン固定パラフィン包埋(FFPE)組織及びその他生物サンプル種類から、遺伝子発現レベルの変化を検出するのに適している。製品は「HTG」エッジシステム、「HTG」エッジアッセイ及び「HTG」アッセイダイレクトを含む。「HTG」エッジシステムは24時間未満で、生物学的サンプル(組織、血液、血清、細胞)の多数の抽出フリー・多重化結果を提供する自動化RNA解析プラットフォームである。「HTG」エッジDMPKアッセイは、研究者の前臨床試験における薬物代謝の特徴づけを可能にする47遺伝子アッセイである。「HTG」エッジトップオンコジーンアッセイは新鮮又は固定生物試料において32の最も一般的に検定した癌遺伝子の発現レベルの測定を行う。   HTGモレキュラ―・ダイアグノスティックスは米国の医療関連診断システムメ―カ―。複雑な分子プロファイリングの日常的な使用を容易にするための新たな技術プラットフォ―ムの開発、販売に従事。主要製品として、計装、消耗品、ソフトウェア解析から成るHTGエッジプラットフォ―ムを提供し、遺伝子および遺伝子活性の分子プロファイリングの自動化を実現する。   HTG Molecular Diagnostics, Inc. engages in the provision of molecular technology solutions that facilitates molecular profiling. It offers instruments, reagents and services for molecular profiling applications. The firm serves biopharmaceutical companies, academic research centres, and molecular testing laboratories. Its proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. The company was founded by Bruce E. Seligmann in October 1997 and is headquartered in Tucson, AZ.
本社所在地 3430 E. Global Loop Tucson AZ 85706 USA
代表者氏名 Ann F. Hanham アンF.ハナム
代表者役職名 Independent Chairman of the Board
電話番号
設立年月日 35704
市場名 NASDAQ Small Cap
ipoyear 2015年
従業員数
url www.htgmolecular.com
nasdaq_url https://www.nasdaq.com/symbol/htgm
adr_tso
EBITDA EBITDA(百万ドル) -14.64091
終値(lastsale) 3.955
時価総額(marketcap) 112407867.005
時価総額 時価総額(百万ドル) 100.61290
売上高 売上高(百万ドル) 20.69706
企業価値(EV) 企業価値(EV)(百万ドル) 77.05323
当期純利益 当期純利益(百万ドル) -16.78553
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 HTG Molecular Diagnostics Inc revenues increased from $3.1M to $9.1M. Net loss decreased 19% to $9.5M. Revenues reflect Collaborative development services increase from $2.2M to $5.3M Product and product-related services increase from $948K to $3.8M. Lower net loss reflects Interest expense decrease of 44% to $416K (expense) Interest income increase from $30K to $331K (income).

 HTGMのテクニカル分析


 HTGMのニュース

   HTG Molecular Provides Update on Patent Infringement Claims Against BioSpyder  2020/08/14 18:17:00 GlobeNewswire
TUCSON, Ariz., Aug. 14, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance…
   BioSpyder Files Action Against HTG Molecular Diagnostics in Federal Court  2020/08/13 21:45:00 Business Wire
CARLSBAD, Calif.--(BUSINESS WIRE)--On Wednesday, August 12, 2020, BioSpyder Technologies, Inc. (“BioSpyder”) filed a civil action in the federal court for the Northern District of California, seeking a declaratory judgment that the BioSpyder TempO-Seq gene expression profiling assay does not infringe any valid claim in U.S. Patent No. 8,741,564 (“the ’564 patent”) for Quantitative Nuclease Protection Assay (QNPA) and Sequencing (QNPS) Improvements. HTG Molecular Diagnostics, Inc. (“HTG”) has re
   HTG Molecular Diagnostics Announces New Commercialization and Distribution Agreement for Companion Diagnostics with QIAGEN  2020/08/10 20:01:00 GlobeNewswire
TUCSON, Ariz., Aug. 10, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance…
   HTG Molecular Diagnostics to Announce Second Quarter 2020 Financial Results and Host Conference Call on Tuesday, August 11  2020/08/05 20:01:00 GlobeNewswire
TUCSON, Ariz., Aug. 05, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a diagnostic company whose mission is to advance…
   HTG Launches New HTG EdgeSeq Pan B-Cell Lymphoma Panel  2020/07/28 20:05:00 GlobeNewswire
TUCSON, Ariz., July 28, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance…
   HTG Molecular Diagnostics Secures Senior Term Loan from Silicon Valley Bank  2020/06/25 20:01:00 GlobeNewswire
TUCSON, Ariz., June 25, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance…
   HTG Adds Three New Distributors in Europe, Expanding and Strengthening Reach in the Nordics and Eastern Europe  2020/06/11 20:01:00 GlobeNewswire
TUCSON, Ariz., June 11, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance…
   HTG Molecular Diagnostics Inc (HTGM) Reports Q1 Loss, Misses Revenue Estimates  2020/05/13 21:25:03 Zacks Investment Research
HTG Molecular Diagnostics Inc (HTGM) delivered earnings and revenue surprises of 0.00% and -2.41%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
   HTG Molecular Diagnostics Inc (HTGM) May Report Negative Earnings: Know the Trend Ahead of Q1 Release  2020/05/07 16:30:51 Zacks Investment Research
HTG Molecular Diagnostics Inc (HTGM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   Earnings Preview: HTG Molecular Diagnostics, Inc. (HTGM) Q4 Earnings Expected to Decline  2020/02/27 17:30:46 Zacks Investment Research
HTG Molecular Diagnostics, Inc. (HTGM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   Earnings Preview: HTG Molecular Diagnostics, Inc. (HTGM) Q4 Earnings Expected to Decline  2020/02/27 17:30:46 Zacks Investment Research
HTG Molecular Diagnostics, Inc. (HTGM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   HTG Announces the Launch of its New Autoimmune Profiling Assay  2019/10/15 12:00:00 ACI Information Group
HTG Molecular Diagnostics, Inc. (HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced it will begin taking orders for its new 2,002-gene HTG EdgeSeq Autoimmune Panel, which is expected to be commercially available for purchase in kit form or as a service in
   HTG Molecular to Present Corporate Overview at the Cantor 2019 Global Healthcare Conference  2019/09/30 12:00:00 Yahoo Finance
TUCSON, Ariz., Sept. 30, 2019 -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced that.
   The Daily Biotech Pulse: ESMO Conference Gets Underway, J&J's Darzalex Snags Another Approval, Kaleido Biosciences CFO To Leave  2019/09/27 11:56:12 Benzinga
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Sept. 26.) AstraZeneca plc (NYSE: AZN ) GlaxoSmithKline plc (NYSE: GSK ) Sanofi SA (NASDAQ: SNY ) ZEALAND PHARMA/S ADR (NASDAQ: ZEAL ) Down In The Dumps (Biotech stocks that hit 52-week lows Sept. 26.) ABIOMED, Inc. (NASDAQ: ABMD ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) Aduro BioTech Inc (NASDAQ: ADRO ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Akcea Therapeutics Inc (NASDAQ: AKCA ) Amicus Therapeutics, Inc. (NASDAQ: FOLD ) AnaptysBio Inc (NASDAQ: ANAB ) Aridis Pharmaceuticals Inc (NASDAQ: ARDS ) AzurRx BioPharma Inc (NASDAQ: AZRX ) Bellerophon Therapeutics Inc (NASDAQ: BLPH ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) (announced submission of clinical trial application to U.K. regulators for its investigational therapy for phenylketonuria) BioNano Genomics Inc (NASDAQ: BNGO ) BridgeBio Pharma Inc (NASDAQ: BBIO ) Calithera Biosciences Inc (NASDAQ: CALA ) Catalyst Biosciences Inc (NASDAQ: CBIO ) Cellectis SA (NASDAQ: CLLS ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Corvus Pharmaceuticals Inc (NASDAQ: CRVS ) CytomX Therapeutics Inc (NASDAQ: CTMX ) strong>DiaMedica Therapeutics Inc (NASDAQ: DMAC ) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX ) Enanta Pharmaceuticals Inc (NASDAQ: ENTA ) ( announced mid-stage results of NASH treatment candidate) Enochian Biosciences Inc (NASDAQ: ENOB ) Erytech Pharma SA (NASDAQ: ERYP ) Five Prime Therapeutics Inc (NASDAQ: FPRX ) Gemphire Therapeutics Inc (NASDAQ: GEMP ) Gritstone Oncology Inc (NASDAQ: GRTS ) HTG Molecular Diagnostics Inc (NASDAQ: HTGM ) IGM Biosciences Inc (NASDAQ: IGMS ) (initial public offering on Sept.
   Could HTG Molecular Diagnostics, Inc.'s (NASDAQ:HTGM) Investor Composition Influence The Stock Price?  2019/09/20 15:02:06 Yahoo Finance
The big shareholder groups in HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) have power over the company. Insiders…

 関連キーワード  (先端医療機器_テクノロジ― 米国株 HTGモレキュラ―・ダイアグノスティックス HTGM HTG Molecular Diagnostics Inc.)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)